We can rely on a few instruments to evaluate severity of infection: lymphopenia, higher blood cell count and higher neutrophil count, in association with non specific markers, such as lower albumin, higher prothrombin time and higher D-Dimer, commonly altered in cancer patients, are predictors of poorer outcome during COVID-19 [5,6]. This evidence concerns the gene ALB and cancer.